In this study, we assessed the spectrum of BCL6 protein in glioblastoma survival and therapy resistance, and demonstrated a key role for BCL6 in survival of glioblastoma cells in vitro after DNA damage. This evidence concerns the gene BCL6 and glioblastoma.